nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 29th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
63.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
64.0
|
80.00
|
80.00
|
3.10
|
3.40
|
2.70
|
3.00
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:29PM
|
Aug 29th, 2022 12:29PM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 28th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
63.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
64.0
|
80.00
|
80.00
|
3.10
|
3.40
|
2.70
|
3.00
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:29AM
|
Aug 28th, 2022 05:29AM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 27th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
63.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
|
63.0
|
65.0
|
64.0
|
80.00
|
80.00
|
3.10
|
3.40
|
2.70
|
3.00
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 04:48AM
|
Aug 27th, 2022 04:48AM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 25th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
63.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
64.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:27AM
|
Aug 25th, 2022 09:27AM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 23rd, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
64.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
63.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 11:20AM
|
Aug 23rd, 2022 11:20AM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 21st, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
64.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
63.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 01:04PM
|
Aug 21st, 2022 01:04PM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 20th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
64.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
63.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
23.00
|
About a week
|
28.00
|
MEDIUM
|
23.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 02:42PM
|
Aug 20th, 2022 02:42PM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 19th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
64.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
63.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
22.00
|
About a week
|
27.00
|
MEDIUM
|
22.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 01:04PM
|
Aug 19th, 2022 01:04PM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 18th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
64.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
63.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
22.00
|
About a week
|
27.00
|
MEDIUM
|
22.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 04:48AM
|
Aug 18th, 2022 04:48AM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:qdel
|
https://www.indeed.com/cmp/quidel-corporation
|
Aug 17th, 2022 12:00AM
|
Open
|
Quidel Corporation
|
|
Healthcare
|
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the diagnostic industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
|
RRv1_100M_500M
|
San Diego, CA
|
|
|
|
3.30
|
64.0
|
59.0
|
67.0
|
58.0
|
55.0
|
56.0
|
53.0
|
55.0
|
51.0
|
57.0
|
56.0
|
63.0
|
65.0
|
63.0
|
79.00
|
79.00
|
3.10
|
3.40
|
2.70
|
2.90
|
3.40
|
22.00
|
About a week
|
27.00
|
MEDIUM
|
22.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 10:27AM
|
Aug 17th, 2022 10:27AM
|
Quidel
|
Health Care
|
Health Care Equipment & Services
|